RT Journal Article
SR Electronic
T1 Feasibility of Identifying Factors Related to Alzheimer’s Disease and Related Dementia in Real-World Data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.02.10.24302621
DO 10.1101/2024.02.10.24302621
A1 Chen, Aokun
A1 Li, Qian
A1 Huang, Yu
A1 Li, Yongqiu
A1 Chuang, Yu-neng
A1 Hu, Xia
A1 Guo, Serena
A1 Wu, Yonghui
A1 Guo, Yi
A1 Bian, Jiang
YR 2024
UL http://medrxiv.org/content/early/2024/02/21/2024.02.10.24302621.abstract
AB A comprehensive understanding of factors associated with Alzheimer’s disease (AD) and AD-related dementias (AD/ADRD) will significantly enhance efforts when designing new studies to develop new treatments and identify high-risk populations for prevention. We reviewed existing meta-analyses and review articles on AD/ADRD risk and preventive factors, extracting 477 risk factors across 10 categories from 537 studies. An interactive knowledge graph was created to share our study findings. Most risk factors can be found in structured Electronic Health Records (EHRs), with clinical narratives also providing valuable information. However, assessing genomic risk factors using real-world data (RWD) like EHRs remains a challenge, as genetic testing for AD/ADRD is still not a common practice and poorly documented in both structured and unstructured EHRs. Given the constant and rapid evolution of AD/ADRD research, using natural language processing (NLP) for literature mining emerges as a viable method to continually and automatically update our knowledge graph.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was in part supported by National Institute of Health grants R01AG080991, R56AG069880, R01AG083039, RF1AG084178, R01 AG084236, RF1AG077820, and R01AG080991.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of University of Florida gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe OneFlorida electronic health record data are considered Protected Health Information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) in the United States, and as such are not publicly-available.